The UAB-HudsonAlpha Center for Genomic Medicine will span human genome research – studying the complexities of the human DNA to understand, at a molecular level, the genetic underpinnings for the onset and progression of diseases – with clinical care, incorporating research knowledge into predicting and diagnosing diseases, and developing personalized therapies and cures.
The partnership formalizes a long-time collaborative relationship and combines HudsonAlpha’s unique concentration of genomics expertise, technologies and infrastructure with UAB’s leadership in academic research and clinical medicine that makes the translation of genetic discoveries into patient care possible. The Center was approved by the University of Alabama System Board of Trustees on Friday, June 13, 2014; final approval is expected by the board of directors of HudsonAlpha later this summer.
“This partnership offers great opportunities for our faculty to help lead the effort to incorporate genomics into routine medical care. It provides an opportunity for us to be national leaders in medical genomics research and to provide the most advanced care to our patients,” said Bruce Korf, M.D., chair of the Department of Genetics in the School of Medicine.
“HudsonAlpha is one of a handful of nationally recognized genomic research centers,” Korf said. “Very few academic medical centers have direct access to the technology and expertise that HudsonAlpha provides. HudsonAlpha has tremendous depth in genomics and bioinformatics, and UAB has depth in genetic medicine. Together we can accomplish more than either one of us could accomplish separately.”
“Our alliance to provide personalized care for patients is very exciting,” said Richard M. Myers, Ph.D., president and science director of HudsonAlpha. “UAB is an outstanding institution that has provided world-class medical care to our state for decades. Human genomic medicine is an important part of our research portfolio, which also includes our research in basic genetics, plant genomics, bioenergy and animal genomics. We look forward to expanding even further into the genomic medicine area even further with UAB because our projects to-date have yielded important discoveries that will impact patient care.”
Korf and Myers will co-direct the UAB-HudsonAlpha Center for Genomic Medicine, with the administrative function managed by UAB’s Department of Genetics. The Center will be made up of a cross-section of scientists and physicians from UAB and HudsonAlpha scientists working at both campuses. It will yield economic, scientific, clinical and educational rewards, including the ability to recruit more world-class scientists and physicians to the region and a competitive edge when applying for research grants and contracts, Korf said.
“We are going to be launching significant initiatives that will allow us to incorporate genomics into the fabric of our research at a higher level. This means more contracts, more grants and more activity that will translate into new jobs and new discoveries,” Korf said.
Selwyn M. Vickers, M.D., senior vice president for Medicine and dean of the UAB School of Medicine, said, “The UAB-HudsonAlpha Center for Genomic Medicine is both a significant biotechnology enterprise that elevates Alabama as a place for cutting-edge research and a catalyst for personalized medicine for patients in Alabama and across the Southeast.
The Center, Korf and Myers said, has three aims initially:
- building research teams with scientists across UAB in areas such as cancer, diabetes, cardiology, neurology and rheumatology with the goal of integrating genomic information into medical care for each of the disease areas;
- wide-scale genetic sequencing aimed at discovering genes responsible for a number of medical disorders; and,
- building a program to educate researchers and physicians so they can incorporate genomic information in their day-to-day research or patient care as well as opening training opportunities for graduate students and medical trainees.
“HudsonAlpha faculty seek to collaborate with people and organizations that tackle important and intriguing challenges,” Myers said. “The scientists and clinicians at UAB fit that description very well. This collaboration exemplifies the power of partnership, connecting UAB’s long-standing expertise in clinical genetics and patient care with HudsonAlpha’s proficiency in genomic sequencing and analysis. Together we can achieve greater insight into the biology behind disease onset, progression and patient response to treatments.”
“Genomics has the potential to impact every person because changes in each individual’s unique DNA can influence whether that person is healthy, develops disease, or will respond to various therapies. The future of medicine lies in incorporating genomic analysis and technology into the health care system where patients are diagnosed and treated,” Myers said.